The legalization movement of magical mushrooms in the US seems to be continuing.
Last year, Santa Cruz, California, decided to decriminalize the use of psychedelic mushrooms within its limits, becoming the third city in the United States to do so, after Oakland (California) and Denver (Colorado).
However, the decision does not make the magic mushrooms completely legal. The active ingredients they contain, psilocybin and psilocin, are still classified by the federal government as List 1 drugs. But legalization activists are already working for additional victories, basing their efforts on recent studies that show the therapeutic effects of these substances. Recent research has found that low doses of psilocybin may increase the effects of psychological interventions in depression and post-traumatic stress disorders. According to companies that produce psychedelic mushroom spores for research, at least two psilocybin-based treatments are subject to approval by the Food and Drug Administration, although clinical trials are still ongoing.
With Connecticut and Texas also enacting laws, this year, allowing research into the effects of psilocybin, it is expected that psychedelic mushrooms will slowly, but steadily, be used as mainstream medicine, as an aid for mental health issues. Some specialists already talk about the future psychedelic-assisted therapies, considering them as a tremendous promise in the treatment of illnesses that resist to common therapies.